Form 4: Trupanion CEO Margaret Tooth Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Trupanion CEO Margaret Tooth sold 2,294 shares of common stock at $31.39 per share on March 4, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 4, 2025, Margaret Tooth, CEO of Trupanion, Inc. sold 2,294 shares of Trupanion's common stock.
- The shares were sold at a price of $31.39 per share.
- Following the transaction, Ms. Tooth directly owns 118,784 shares of Trupanion common stock.
- The sale was executed under a Rule 10b5-1 trading plan adopted on November 29, 2024, for financial diversification purposes.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Insider sales, especially by CEOs, are closely watched by investors. Sales under 10b5-1 plans are generally viewed as less concerning since they are pre-arranged and not based on current insider information. However, the market may still react to the news, depending on the size of the sale and overall market sentiment.
Stakeholder Impact
- The sale could have a minor negative impact on shareholder sentiment, although the existence of the 10b5-1 plan mitigates this.
Key Dates
| Date | Description |
|---|---|
| 2024-11-29 | Date of adoption of Rule 10b5-1 trading plan |
| 2025-03-04 | Date of stock sale transaction |
| 2025-03-05 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.